Erenumab in chronic migraine: Experience from a UK tertiary centre and comparison with other real-world evidence.

Modar Khalil Peter J GoadsbyMaría Dolores Villar-MartínezFiona GreenwoodJan Hoffmann Peter J Goadsby

Published in: European journal of neurology (2022)

Our real-world data with erenumab demonstrate it is effective and well tolerated in managing patients with chronic migraine in a tertiary care setting.

Keyphrases

tertiary care
electronic health record
big data
cross sectional
clinical evaluation